Catalio Capital Management, LP
Catalio Capital Management, LP is a New York-based investment firm founded in 2020. The firm specializes in the full lifecycle of innovative healthcare investing across private, public, and credit markets, supporting category-defining businesses in life sciences and biotechnology. Catalio is led by a team of managing partners, associates, and a board of advisors, with a network of renowned scientist-entrepreneurs as Venture Partners. The firm employs approximately 36 professionals and manages more than $1.7 billion in assets for institutional and sophisticated investors.
Investment Strategy
Catalio Capital Management invests in innovative healthcare companies at all stages and across the capital structure, including private equity, structured opportunities, and public equities. The firm leverages a proprietary network of scientist-entrepreneurs for rigorous scientific due diligence and aims to advise on disruptive trends in life sciences by providing early exposure to biomedical technologies. Catalio's investment approach is driven by deep scientific insight, a focus on emerging healthcare innovations, and the ability to generate value throughout companies' life cycles.
Top Holdings
Equity Positions (39)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
L LLY | ELI LILLY & CO | 8.81% | $42.0M | 53,916 | $799.90 | $779.53 | +$22.5M |
B BBIO | BRIDGEBIO PHARMA INC | 8.40% | $40.1M | 927,711 | $27.92 | $43.18 | +$6.8M |
S SLNO | SOLENO THERAPEUTICS INC | 7.20% | $34.3M | 409,944 | $78.94 | $83.78 | +$22.8M |
A ASND | ASCENDIS PHARMA A/S | 6.51% | $31.1M | 179,926 | $137.67 | $172.60 | +$581.0K |
I ISRG | INTUITIVE SURGICAL INC | 6.46% | $30.8M | 56,674 | $529.60 | $543.41 | +$12.7M |